Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Coronavirus Pandemic Expected to Significantly Disrupt Hologic Q2 Revenues

Coronavirus Pandemic Expected to Significantly Disrupt Hologic Q2 Revenues

Apr 07, 2020
|
staff reporter

NEW YORK – Citing the effects of the coronavirus pandemic, Hologic said Tuesday that it expects to report total revenues of $756.1 million for its fiscal second quarter, down 8 percent from $818.4 million in Q2 2019.

The firm also withdrew its 2020 financial guidance due to the uncertain economic impact on its business of the COVID-19 pandemic.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Not Quite There Yet

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

Call for Open Science

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Accolades for a New University

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

Nucleic Acids Research Papers on IndiGenomes, DockCoV2, ViruSurf Databases

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.

Oct
29
Featured Webinar

How to Train Your DRAGEN for Pathology Informatics

Sponsored by
Illumina

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

Nov
03
Featured Webinar

A Streamlined Targeted NGS Workflow for Comprehensive Genomic Profiling of Different Tumor Samples

Sponsored by
Agilent

Molecular tumor profiling has provided extensive value, both in tumor biology and oncology, with the development of new technologies to identify biomarkers.

Nov
05
Featured Webinar

Beyond Traditional Biopsy for Esophageal Cancer: Novel Sampling Methods to Improve Patient Care

Sponsored by
Roche

This webinar will provide an overview of novel proximal and distal sampling methods that have promise to improve patient outcomes from esophageal cancer.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Molecular Diagnostics

  1. Exact Sciences to Acquire Thrive Earlier Detection for up to $2.15B; Q3 Revenues Spike 87 Percent

  2. Biodesix Prices $72M IPO

  3. Exact Sciences Aiming to Make Pan-Cancer Blood Screening Part of Standard Medical Care

    Premium

  4. Qiagen Reports 26 Percent Q3 Revenue Growth; Ups Full-Year Guidance

  5. Illumina's ExpansionHunter Software Shows Clinical Promise for STR Expansions

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.